Stay updated on Pembrolizumab Combo in Gastro Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Gastro Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Gastro Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded a dedicated Locations section listing Georgia, New Jersey, and New York, consolidating the previous state entries. Updated the page to revision v3.3.3 and removed the HHS Vulnerability Disclosure link.SummaryDifference0.4%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedAdded Revision: v3.3.2 and removed Revision: v3.2.0 on the page.SummaryDifference0.1%

- Check49 days agoChange DetectedThe funding-status notice was removed from the page; the main study details, eligibility criteria, and study plan remain unchanged.SummaryDifference0.4%

- Check63 days agoChange DetectedMinor formatting adjustments and an updated 'Last Update Posted' timestamp were observed, with no changes to inclusion criteria, primary outcomes, or treatment details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check91 days agoChange DetectedUpdate includes a funding/status notice and a version bump to v3.2.0, replacing the previous v3.1.0.SummaryDifference3%

- Check99 days agoChange Detected- Updated the revision tag from v3.0.2 to v3.1.0. This is a core page content change indicating a new software version release.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Combo in Gastro Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Gastro Cancer Clinical Trial page.